United States · What does Nektar Therapeutics invest in?
Nektar Therapeutics invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Chemical and Health Care.
Nektar Therapeutics highlights
- 01
1 rounds on record
- 02
Mostly Series A: 100% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyChemicalHealth Care
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2008
1 round
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Pearl TherapeuticsBought by AstraZeneca$1.1BJun 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.